Metabolic liver diseases are excellent targets for correction using novel stem cell, hepatocyte, and gene therapies. In this study, the use of bone marrow stem cell transplantation to correct liver disease in the toxic milk (tx) mouse, a murine model for Wilson's disease, was evaluated. Preconditioning with sublethal irradiation, dietary copper loading, and the influence of cell transplantation sites were assessed. Recipient tx mice were sublethally irradiated (4 Gy) prior to transplantation with bone marrow stem cells harvested from normal congenic (DL) littermates. Of 46 transplanted tx mice, 11 demonstrated genotypic repopulation in the liver. Sublethal irradiation was found to be essential for donor cell engraftment and liver repopulation. Dietary copper loading did not improve cell engraftment and repopulation results. Both intravenously and intrasplenically transplanted cells produced similar repopulation successes. Direct evidence of functionality and disease correction following liver repopulation was observed in the 11 mice where liver copper levels were significantly reduced when compared with mice with no liver repopulation. The reversal of copper loading with bone marrow cells is similar to the level of correction seen when normal congenic liver cells are used. Transplantation of bone marrow cells partially corrects the metabolic phenotype in a mouse model for Wilson's disease. 765 766 ALLEN ET AL.
INTRODUCTION
marrow cells to existing liver cells, rather than transdifferentiation of bone marrow cells into liver cells, is the The contribution of bone marrow cells to the renewal major mechanism from which functionally normal hepaof hepatocytes has the potential to treat liver injury and tocytes arise (3, 7, 9, 27, 31, 35, 39) . acute or chronic liver failure. The entry mechanism of Wilson's disease is an autosomal recessive copper transplanted bone marrow cells into the liver, and the transport disorder resulting from defective biliary excremechanism by which these cells correct liver disease, tion of copper and subsequent hepatic copper accumulahas not been clearly elucidated. The promotion of a setion. It causes liver failure if not treated. The disease is lective growth advantage of donor cells over hepatocytes caused by mutations in the WND gene, which is exin the recipient liver is one method of optimizing cell pressed predominantly in the liver and encodes a copentry and function of donor cells. This may be achieved per-transporting P-type ATPase, ATP7B. As a result of by using radiation or chemicals to induce tissue damage the inherited absence or dysfunction of copper transport in the recipient liver. Low-level irradiation of the liver is (6) , Wilson's disease is characterized by the inability of known to cause slight perturbations in liver cell turnover the liver to metabolize copper. without inducing histological damage (29) . There are a
The ATP7B transporter has two functions: transport number of reports describing the reconstituting effects of copper into the plasma protein ceruloplasmin (a seof bone marrow cells (20,37). These stem cells appear rum ferroxidase that contains greater than 95% of the capable of engrafting into many different organs. Curcopper found in plasma), and elimination of copper rent literature suggests that spontaneous fusion of bone through the bile. Biliary excretion is the primary mecha-nism for copper excretion, and thus individuals affected mice (group 8) were culled at 7.5 months of age (4.5 months posttransplantation). Twenty-one age-matched by Wilson's disease have progressive copper accumulation in the liver, which eventually exceeds the metallo-(12-15 months) mice served as controls. thionein binding threshold. Toxic liver cell injury then Irradiation Protocol causes hepatic symptoms ranging from mild acute or chronic active hepatitis to liver cirrhosis and failure.
The tx mice were sublethally irradiated (4 Gy) the day before bone marrow cell transplantation. Copper released into the bloodstream is also deposited in other tissues in the body, including kidney, cornea, Bone Marrow Extraction From DL Mice joints, spleen, and CNS. The clinical presentation of for Transplantation Wilson's disease often results from these other sites of copper deposition, even though the primary site of tissue Eight-to 10-week-old congenic mice (DL) were humanely culled for bone marrow extraction. Femur and failure is the liver.
The primary therapeutic intent in Wilson's disease is tibia were flushed with RPMI with 10% fetal calf serum (referred further only as RPMI) to extract bone marrow to restore hepatic copper homeostasis via copper chelation therapy (21,36). Whole-organ liver transplantation cells. The cell suspension was filtered through nylon mesh and centrifuged for 7 min (12,000 × g) at room allows the recipient to metabolize copper correctly, preventing progression of disease and in many cases revers-temperature. Ammonium chloride (0.83%, w/v) and sodium carbonate (0.084%, w/v) were added to the tubes ing the neurological consequences of Wilson's disease (21, 36) . and placed on ice for 2 min. The cells were washed and resuspended in RPMI for transplantation at a concentra-The toxic milk mouse (tx) is a mouse model of Wilson's disease (22) that has a point mutation in the mu-tion of 5 × 10 6 bone marrow cells/100 µl RPMI. rine homologue of the WND gene (ATP7B). It is an Transplantation of Bone Marrow Cells accurate genotypic model for Wilson's disease and exhibits a mild form of this metabolic liver disorder (15, For intrasplenic (IS) transplantation of bone marrow cells, mice were anesthetized with 2.5% v/v Avertin (17 23,30) . Our group has previously demonstrated phenotypic correction using this mouse model following trans-µl/g of body weight) and a 1-cm surgical incision made just below the costal margin on the left lateral side of plantations with congenic liver cells (2) . This present study was conducted to determine if unsorted bone mar-the mouse to reveal the lower splenic pole. A 4/0 silk surgical ligature was loosely placed at the tip of the row cells were capable of correcting Wilson's disease in the tx mouse. The effectiveness of preconditioning the spleen. A 30-gauge needle was used to rapidly inject (over 10 s) the cell suspension into the body of the animals with sublethal irradiation and dietary copper loading, as well as the method and site of cell transplan-spleen. The spleen was then gently replaced and the abdomen closed. tation in relation to donor cell engraftment and repopulation, was also assessed.
For intravenous (IV) transplantation, 100 µl of bone marrow cell suspension was rapidly injected into the MATERIALS AND METHODS mouse tail vein over 10 s. All mice received transplants of 5 × 10 6 bone marrow All reagents used were of analytical grade. Enzymes were purchased from Roche (Basel, Switzerland), unless cells/100 µl RPMI except group 8, which received 1 × 10 6 bone marrow cells/100 µl RPMI. otherwise specified. The Royal Children's Hospital Animal Research Ethics Committee approved the experi-Copper Loading Protocol mental protocol.
Dietary copper loading commenced when the mice Mouse Husbandry were 2-3 months old and continued posttransplantation for the duration of the study. Copper in the form of cop-All mice used in this study were kept and cared for in the mouse house facility at the Murdoch Childrens per acetate (Merck, Darmststadt, Germany) was dissolved in the drinking water to the concentration of Research Institute. The copper level of the water was measured at <0.000005% w/v. Both water and food 0.03% (w/v). The mice were gradually introduced to the copper water over a period of 2 weeks to ensure that were provided ad libitum.
Experimental tx mice were randomly allocated to 1 they were accustomed to the taste. of 10 groups (Table 1) 
. At the time of transplantation
Collection of Tissue for Analysis the mice ranged in age from 7 to 9 months, except group 8, which were transplanted at 3 months of age. Of 67 Liver, spleen, kidney, and brain tissues were collected from all experimental animals, and stored in acid-experimental mice, 62 were culled between 12 and 15 months of age (6-8 months posttransplantation). Five washed Eppendorf tubes at −20°C for subsequent trace metal analysis. Tissue collected from liver, spleen, tail, key's b" post hoc analysis. All data are presented as mean ± SE. and bone marrow for PCR analysis was stored immediately at −80°C until analysis. Bone marrow was not col-RESULTS lected from group 2 and group 8. Blood was collected Engraftment and Repopulation Posttransplantation in heparin-containing tubes and centrifuged at 7500 × g for 10 min to obtain serum. Fluid samples (urine and Liver, spleen, tail, and bone marrow samples were bile) were also collected; however, insufficient numbers collected and analyzed by PCR/NcoI digestion. Liver, were available for analysis. spleen, and tail were sampled from all 46 transplanted animals; however, only 29 bone marrow samples were Trace Metal Analysis collected. Evidence of mixed patterns of DL and tx PCR fragments in recipient tx mouse liver, spleen, and bone Levels of copper, iron, and zinc were determined by atomic absorption spectroscopy (AAS) using the method marrow indicated engraftment and expansion of donorderived cells (Fig. 1 ). Tail biopsies were performed on of Michalczyk et al. (19) . All results were expressed in µg/g dry weight of tissue.
all tx recipients to confirm their genotype. Thus, any evidence of DL DNA, as defined by the presence of the Analysis of Ceruloplasmin Oxidase Activity 345-bp band, was indicative of successful cell transplantation. Analysis of mRNA showed no repopulation in Serum analysis of ceruloplasmin oxidase activity was the organs analyzed (data not shown). For statistical determined using the method of Schosinsky et al. (24). analysis, mice were regarded as "repopulated" when ≥10% DL DNA (345-bp band) was visually detected. In Polymerase Chain Reaction of WND Gene animals defined as "nonrepopulated," the percentage of Tissue was digested in proteinase K-containing solu-DL DNA was below the 10% detection limit. Repopulation overnight at 55°C and DNA purified as described tion of donor cells was demonstrated in the liver of 11 in Current Protocols for Molecular Biology (26) . PCR mice, the spleen of 18 mice, and bone marrow of 13 was used to amplify the WND gene, which was subsemice (Table 1) . quently digested with NcoI as previously described (2). The PCR product, containing the gene sequence for a Influence of Irradiation on Repopulation normal DL mouse, produces four fragments of 345, 193, Sublethal irradiation appears to be essential for donor 103, and 18 bp in length after the NcoI digestion. The cell repopulation in the liver, spleen, and bone marrow. tx mouse mutation removed a NcoI digestion site, result-In the irradiated groups, bone marrow repopulation was ing in only three fragments: 448, 193, and 18 bp. demonstrated in 12 of 14 (86%) samples collected and To assess the sensitivity of the PCR assay, DNA mixanalyzed, while 11 of 20 (55%) mice showed donor cell ing studies were performed. Increasing amounts of DL repopulation in the liver and 17 of 20 (85%) had repopu-DNA, ranging from 1% to 20%, were mixed with tx lation in the spleen. In contrast, only one animal in the DNA and, after PCR and restriction enzyme digestion, nonirradiated group demonstrated donor cell repopulathe presence of the 345-bp fragment was assessed on tion in the spleen and bone marrow. agarose gels.
Influence of Copper Loading on Repopulation Reverse Transcription-PCR of ATP7B Gene
Copper loading did not influence the likelihood of RNA was isolated from liver samples using the TRI donor cell repopulation in the liver, spleen, or bone marreagent (Molecular Research Center, Cincinnati, OH) row. A comparison of copper-loaded and non-coppermethod. The mRNA was reverse transcribed and a loaded mice demonstrated repopulation in 2 of 21 nested PCR protocol used to amplify ATP7B cDNA (2).
(9.5%) and 9 of 25 (36%) livers, respectively, 8 of 21 PCR of the cDNA resulted in a 653-bp product that, (38%) and 10 of 25 (40%) spleens, respectively, and 10 when digested with NcoI, produced two fragments of of 25 (40%) and 3 of 12 (25%) bone marrow, respec-417 and 236 bp for the tx mouse mutation, and three tively. fragments (285, 236, and 132 bp) for the congenic DL Influence of Cell Delivery Route on Repopulation mouse.
There was no difference in the efficiency of donor Data Analysis cell liver repopulation based on the transplantation procedure (IV or IS). The IV transplanted groups demon-Analysis of data by one-way ANOVA was performed using the SPSS (Statistical Package for Social Sciences, strated repopulation in 6 of 23 (26%) liver, 11 of 23 (48%) spleen, and 7 of 13 (54%) bone marrow samples. Version 11.5) program. Data were considered significant when p < 0.05. Significance was determined by "Tu-Of the IS transplanted groups, repopulation was demon- Table 2 ). The decrease in liver copper achieved with the transplanted 6 of 15 (40%) bone marrow samples.
bone marrow cells was equivalent to that of the hepato-Effect of Cell Transplantation on Trace Metal Levels cyte transplanted tx mice (2) (Fig. 2) . The normal DL mouse average copper concentrations (µg/g dry weight The mice with repopulated livers demonstrated decreased liver, kidney, spleen, and brain copper concen-of tissue) are: liver, 15.1; kidney, 16.4; spleen, 4.7; and Control mice did not receive cell transplantations and were age matched for their respective studies. "Nonrepopulated" mice showed less than 10% donor cell DNA in the liver, while "repopulated" mice had donor DNA in the liver. Liver copper concentrations are presented as mean ± SE. Data were analyzed by one-way ANOVA with p < 0.01 (*). The hepatocyte transplantation results are from 4-5-month-old mice transplanted with 1 × 10 6 cells and culled 4 months later (2). brain, 15.3 (1). The average organ copper levels (µg/g vides direct evidence of functionality and phenotypic correction with bone marrow-derived cells in the liver. dry weight of tissue) in tx mice at 5 months of age are: liver, 887; kidney, 26.3; spleen, 17.3; and brain, It can be presumed that three events have transpired in order for disease correction in the tx mouse model to 26.3 (2) .
It should be noted that there was some reduction in have occurred. First, donor-derived cells have engrafted in the recipient liver. Secondly, there is evidence that kidney and brain copper with a significant reduction in spleen copper compared with controls. It is conceiv-transplanted donor cells have expanded in number in the host liver. The detection of donor DNA in the recipient able that the "nonrepopulated" group includes mice with low levels (<10% DL DNA) of donor cell engraftment liver was greater than 10%, while the quantity of cells transplanted (5 million, less than 8% of the total number that are contributing to the limited levels of disease correction.
of cells in the liver) was low and some cell attrition posttransplantation would be expected to have occurred. Improvement was seen in liver, kidney, and splenic iron levels in the repopulated mice compared with the Thirdly, the donor-derived cells acquired at least the relevant functions consistent with true hepatocytes in order control mice (Table 3) . Additionally, animals from the nonrepopulated groups had decreased liver, kidney, and to correct the underlying metabolic deficit. A comparison of disease correction between bone brain iron compared with control levels. Liver zinc concentrations were also significantly lower in the repopu-marrow-and hepatocyte-transplanted tx mice suggests that bone marrow cells and hepatocytes are equivalent in lated experimental group compared with controls. Other tissue zinc measurements demonstrated no difference their ability to engraft, repopulate, and correct Wilson's disease. The ability of donor-derived bone marrow cells between the experimental groups (data not shown).
to persist for more than 6 months posttransplant and cor-Ceruloplasmin Oxidase Activity rect the metabolic defect provides indirect evidence that these cells have integrated in the liver parenchyma (11) Serum ceruloplasmin oxidase activity (IU/L) was compared between the repopulated (15.7 ± 1.7, n = 10), and either fused with, or have differentiated into, hepatocytes. Although these experiments do not provide evi-nonrepopulated (12.2 ± 0.9, n = 29), and control mice (12.8 ± 1.6, n = 19). There was a slight increase in activ-dence to further illuminate the mechanism of disease correction, they are potentially clinically significant be-ity of repopulated mice compared with nonrepopulated and control mice. The average serum ceruloplasmin oxi-cause they are the first results to demonstrate disease correction in a model of nonlethal liver disease. dase activity in DL mice at 8 months of age is 36.29 ± 4.4 IU/L (2).
The results presented here suggest that donor cells are first taken up in the host bone marrow and subse-DISCUSSION quently engraft the liver, as opposed to a one-stage mechanism with direct uptake of bone marrow cells by The use of bone marrow as an alternative source of cells for disease correction in a mouse model of Wil-the liver. There was little evidence of donor cell engraftment in the liver when donor cells were not detectable son's disease was evaluated. Various methods, including irradiation, were used to maximize donor bone marrow in the bone marrow and or spleen. These results concur with findings by Wang et al., who found that hematopoi-cell engraftment and repopulation in the liver. Repopulation occurred in the livers of 11 out of 46 tx mice that etic stem cell engraftment occurs first, followed by liver repopulation starting about 2 months later (34) . received bone marrow cell transplants. In these 11 mice, liver, spleen, and brain copper concentrations were sig-Selective pressure in the form of liver injury and irradiation is required for cell engraftment of the liver. The nificantly reduced compared with controls. This pro- only mouse model previously showing disease correc-Metallothioneins are involved in metal homeostasis and resistance to toxicity caused by heavy metals and alkyl-tion following bone marrow cell engraftment in the liver is the fumarylacetoacetate hydrolase (FAH)-deficient ating agents. Metallothionein induction occurs when there is an overload of copper (5) . model, which has severe liver dysfunction (16, 31, 33) . The tx mouse model is a milder form of liver disease, Although tx mice do not demonstrate neurological symptoms, brain copper is significantly elevated in these with lower selective pressure.
The use of irradiation has two advantages in that it animals (13) . Following transplantation, a lower brain copper level in the repopulated mice was observed, sug-provides a space for bone marrow cells to target and increases the selective pressure by injuring the host he-gesting that some clearance of copper is occurring. Brain copper in Wilson's disease patients requires long-term patocytes (10) . Theise (17) show cells to the liver (28) . Several groups (4, 8, 14, 16, 20, 32, 33) also followed this lethal irradiation regime. Our reversal of neurological symptoms in patients with Wilson's disease after more than 12 months of treatment. use of sublethal irradiation demonstrated that neither severe liver injury nor lethal irradiation is required for suc-Ceruloplasmin in patients with Wilson's disease is significantly reduced or absent from the plasma. In tx cessful cell engraftment in the liver of the tx mouse model. recipient mice with liver repopulation a slight increase in serum ceruloplasmin levels was observed. This func-Additionally, dietary copper loading does not enhance cell repopulation in the liver. This confirms our tion of the repopulating cells may, like hepatocytes (2), take longer to be initiated. previous results that excess dietary copper does not promote donor cell engraftment in the tx mouse liver (2) .
The site of transplantation did not influence the success of cell engraftment. The IV injection of bone mar-The use of dietary copper loading may create a toxic hepatic environment for the newly transplanted donor row cells results in the presence of donor cells in the recipient (28) , while IS delivery allows donor cells to cells that would eliminate any survival growth advantage, resulting in decreased donor cell expansion over track into the liver from the spleen, resulting in engraftment. In the present study, the mice that received donor time.
Partial disease correction, irrespective of copper load-bone marrow cells by either the IV or the IS route showed similar donor cell repopulation effectiveness. ing status, was demonstrated by a significant lowering of liver, spleen, and brain copper concentrations in the This is clinically valuable, as IV delivery of bone marrow cells to patients with metabolic liver disease is a mice that showed repopulation compared with the control mice. Under normal conditions, copper levels in a relatively noninvasive procedure. This study provides further evidence prompting the tx mouse liver increase until a maximum is reached between 2 and 3 months of age. The decrease in copper need to consider the use of bone marrow cells in the treatment of metabolic liver disease. Bone marrow cell levels shown in this study demonstrated that not only are the bone marrow cells preventing further accumula-transplantation appears to show similar disease correction as transplanted liver cells in our tx mouse model tion but, more importantly, they are reversing the level of the already accumulated copper. Disease prevention system. Currently, clinical liver cell transplant programs are in competition with whole-organ programs for scarce may be possible if cells are transplanted as a prophylactic measure at an age before significant copper accumu-donor organs. If these bone marrow transplantation experiments are validated for other animal models of liver lation has occurred.
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